@article{30aae01b860e45c7bf7145d9ea36fa85,
title = "Boosting the acceptance of 18F-FET PET for image-guided treatment planning with a multi-centric prospective trial",
author = "Langen, {Karl Josef} and Norbert Galldiks and Philipp Lohmann and Mottaghy, {Felix M.}",
note = "Funding Information: FMM is medical advisor for NanoMab Technology Ltd. and Advanced Accelerator Applications (AAA) GmbH/Novartis; holds speaker positions at Siemens, GE Healthcare, and Bayer; and has recently received institutional grants from NanoMab Technology Ltd., Siemens, and GE Precision Healthcare LLC. FMM is supported by the German Research Foundation (DFG) within the framework of the Research Training Group 2375 “Tumor-targeted Drug Delivery” (grant 331065168), the Clinical Research Unit CRU 5011 “Integrating emerging methods to advance translational kidney research (InteraKD)” (project 445703531), and the Research Unit 2591 “Severity assessment in animal-based research” (project 321137804). In addition, his research is funded by German Cancer Aid (projects 70113779 and 70113780) and the German Federal Ministry of Research and Education (project 16GW0319K).",
year = "2023",
month = sep,
day = "8",
doi = "10.1007/s00259-023-06426-7",
language = "English",
volume = "50",
pages = " 3817–3819",
journal = "European Journal of Nuclear Medicine and Molecular Imaging",
issn = "1619-7070",
publisher = "Springer, Cham",
number = "13",
}